Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Exp Neurol. 2017 Jul 28;297:82–91. doi: 10.1016/j.expneurol.2017.07.016

Figure 7.

Figure 7

LPS enhances PMN accumulation in peripheral organs after GCI. Lung IHC (A) and quantitative analyses for average fluorescence intensity of Ly-6B(+) PMNs per mm2 field (B) and alveolar wall thickness (C). PMN accumulation is observed in the liver (D–E) and kidney (F–G) with 3VO/LPS treatment but not with 3VO/SAL. Scale bars = 200 μm. Values represent means ± SD (n = 3–4 per group). AU = arbitrary units. 2-way ANOVA: * Sham vs. 3VO; # SAL vs. LPS. */# p < 0.05, **/## p < 0.01, *** p < 0.001.